ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
  • Category
  • Region
U.S. (TOLL FREE)
+1 (315) 215-3225
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Drug Repositioning Market Insights, Forecast to 2030
Published Date: July 2024
|
Report Code: QYRE-Auto-16V9136
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Drug Repositioning Market Size Status and Forecast 2022
BUY CHAPTERS

Global Drug Repositioning Market Insights, Forecast to 2030

Code: QYRE-Auto-16V9136
Report
July 2024
Pages:111
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Novartis
Johnson & Johnson
Bausch Health
GSK
ChemRar Group
Glenmark
Fujifilm
Dr. Reddy
R-Pharma
Pfizer Inc
TEVA
Mylan NV

Drug Repositioning Market Size

The global Drug Repositioning market is projected to grow from US$ 27610 million in 2024 to US$ 36370 million by 2030, at a Compound Annual Growth Rate (CAGR) of 4.7% during the forecast period.

Drug Repositioning Market

Drug Repositioning Market

Drug repurposing (also called drug repositioning, reprofiling or re-tasking) is a strategy for identifying new uses for approved or investigational drugs that are outside the scope of the original medical indication. This strategy offers various advantages over developing an entirely new drug for a given indication.
Market Analysis and Insights: Global Drug Repositioning Market
Global Drug Repositioning key players include Teva, Novartis, Mylan, Johnson & Johnson, Pfizer, etc. Global top five manufacturers hold a share about 15%.
North America is the largest market, with a share about 40%, followed by Europe and China, both have a share over 30 percent.
In terms of product, Generic Drugs is the largest segment, with a share about 65%. And in terms of application, the largest application is Cancer, followed by Cardiovascular Diseases.
Report Covers:
This report presents an overview of global market for Drug Repositioning market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Drug Repositioning, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Drug Repositioning, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Drug Repositioning revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Drug Repositioning market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Drug Repositioning revenue, projected growth trends, production technology, application and end-user industry.
Market Segmentation

Scope of Drug Repositioning Market Report

Report Metric Details
Report Name Drug Repositioning Market
Accounted market size in 2024 US$ 27610 million
Forecasted market size in 2030 US$ 36370 million
CAGR 4.7
Base Year 2024
Forecasted years 2024 - 2030
Segment by Type
  • Generic Drugs
  • Clinical Trial Failed Drugs
Segment by Application
  • Cardiovascular Diseases
  • Mental Illness
  • Cancer
  • Others
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Teva, Novartis, Mylan, Johnson & Johnson, Pfizer, Bausch Health, GSK, ChemRar Group, Glenmark, Fujifilm, Dr. Reddy, R-Pharma
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Revenue of Drug Repositioning in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Drug Repositioning companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
  • Chapter 7: Europe by Type, by Application and by country, revenue for each segment.
  • Chapter 8: China by Type, and by Application, revenue for each segment.
  • Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment.
  • Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment.
  • Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Drug Repositioning revenue, gross margin, and recent development, etc.
  • Chapter 12: Analyst's Viewpoints/Conclusions

FAQ for this report

How fast is Drug Repositioning Market growing?

Ans: The Drug Repositioning Market witnessing a CAGR of 4.7 during the forecast period 2024-2030.

What is the Drug Repositioning Market size in 2030?

Ans: The Drug Repositioning Market size in 2030 will be US$ 36370 million.

What is the market share of major companies in Drug Repositioning Market?

Ans: Global top five manufacturers hold a share about 15%.

What is the Drug Repositioning Market share by type?

Ans: In terms of product, Generic Drugs is the largest segment, with a share about 65%.

Who are the main players in the Drug Repositioning Market report?

Ans: The main players in the Drug Repositioning Market are Teva, Novartis, Mylan, Johnson & Johnson, Pfizer, Bausch Health, GSK, ChemRar Group, Glenmark, Fujifilm, Dr. Reddy, R-Pharma

What are the Application segmentation covered in the Drug Repositioning Market report?

Ans: The Applications covered in the Drug Repositioning Market report are Cardiovascular Diseases, Mental Illness, Cancer, Others

What are the Type segmentation covered in the Drug Repositioning Market report?

Ans: The Types covered in the Drug Repositioning Market report are Generic Drugs, Clinical Trial Failed Drugs

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Drug Repositioning Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
1.2.2 Generic Drugs
1.2.3 Clinical Trial Failed Drugs
1.3 Market by Application
1.3.1 Global Drug Repositioning Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
1.3.2 Cardiovascular Diseases
1.3.3 Mental Illness
1.3.4 Cancer
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Drug Repositioning Market Perspective (2019-2030)
2.2 Global Drug Repositioning Growth Trends by Region
2.2.1 Drug Repositioning Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Drug Repositioning Historic Market Size by Region (2019-2024)
2.2.3 Drug Repositioning Forecasted Market Size by Region (2025-2030)
2.3 Drug Repositioning Market Dynamics
2.3.1 Drug Repositioning Industry Trends
2.3.2 Drug Repositioning Market Drivers
2.3.3 Drug Repositioning Market Challenges
2.3.4 Drug Repositioning Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Drug Repositioning by Players
3.1.1 Global Drug Repositioning Revenue by Players (2019-2024)
3.1.2 Global Drug Repositioning Revenue Market Share by Players (2019-2024)
3.2 Global Drug Repositioning Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Drug Repositioning, Ranking by Revenue, 2022 VS 2023 VS 2024
3.4 Global Drug Repositioning Market Concentration Ratio
3.4.1 Global Drug Repositioning Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Drug Repositioning Revenue in 2023
3.5 Global Key Players of Drug Repositioning Head office and Area Served
3.6 Global Key Players of Drug Repositioning, Product and Application
3.7 Global Key Players of Drug Repositioning, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Drug Repositioning Breakdown Data by Type
4.1 Global Drug Repositioning Historic Market Size by Type (2019-2024)
4.2 Global Drug Repositioning Forecasted Market Size by Type (2025-2030)
5 Drug Repositioning Breakdown Data by Application
5.1 Global Drug Repositioning Historic Market Size by Application (2019-2024)
5.2 Global Drug Repositioning Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Drug Repositioning Market Size (2019-2030)
6.2 North America Drug Repositioning Market Size by Type
6.2.1 North America Drug Repositioning Market Size by Type (2019-2024)
6.2.2 North America Drug Repositioning Market Size by Type (2025-2030)
6.2.3 North America Drug Repositioning Market Share by Type (2019-2030)
6.3 North America Drug Repositioning Market Size by Application
6.3.1 North America Drug Repositioning Market Size by Application (2019-2024)
6.3.2 North America Drug Repositioning Market Size by Application (2025-2030)
6.3.3 North America Drug Repositioning Market Share by Application (2019-2030)
6.4 North America Drug Repositioning Market Size by Country
6.4.1 North America Drug Repositioning Market Size by Country: 2019 VS 2023 VS 2030
6.4.2 North America Drug Repositioning Market Size by Country (2019-2024)
6.4.3 North America Drug Repositioning Market Size by Country (2025-2030)
6.4.4 United States
6.4.5 Canada
7 Europe
7.1 Europe Drug Repositioning Market Size (2019-2030)
7.2 Europe Drug Repositioning Market Size by Type
7.2.1 Europe Drug Repositioning Market Size by Type (2019-2024)
7.2.2 Europe Drug Repositioning Market Size by Type (2025-2030)
7.2.3 Europe Drug Repositioning Market Share by Type (2019-2030)
7.3 Europe Drug Repositioning Market Size by Application
7.3.1 Europe Drug Repositioning Market Size by Application (2019-2024)
7.3.2 Europe Drug Repositioning Market Size by Application (2025-2030)
7.3.3 Europe Drug Repositioning Market Share by Application (2019-2030)
7.4 Europe Drug Repositioning Market Size by Country
7.4.1 Europe Drug Repositioning Market Size by Country: 2019 VS 2023 VS 2030
7.4.2 Europe Drug Repositioning Market Size by Country (2019-2024)
7.4.3 Europe Drug Repositioning Market Size by Country (2025-2030)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Drug Repositioning Market Size (2019-2030)
8.2 China Drug Repositioning Market Size by Type
8.2.1 China Drug Repositioning Market Size by Type (2019-2024)
8.2.2 China Drug Repositioning Market Size by Type (2025-2030)
8.2.3 China Drug Repositioning Market Share by Type (2019-2030)
8.3 China Drug Repositioning Market Size by Application
8.3.1 China Drug Repositioning Market Size by Application (2019-2024)
8.3.2 China Drug Repositioning Market Size by Application (2025-2030)
8.3.3 China Drug Repositioning Market Share by Application (2019-2030)
9 Asia (excluding China)
9.1 Asia Drug Repositioning Market Size (2019-2030)
9.2 Asia Drug Repositioning Market Size by Type
9.2.1 Asia Drug Repositioning Market Size by Type (2019-2024)
9.2.2 Asia Drug Repositioning Market Size by Type (2025-2030)
9.2.3 Asia Drug Repositioning Market Share by Type (2019-2030)
9.3 Asia Drug Repositioning Market Size by Application
9.3.1 Asia Drug Repositioning Market Size by Application (2019-2024)
9.3.2 Asia Drug Repositioning Market Size by Application (2025-2030)
9.3.3 Asia Drug Repositioning Market Share by Application (2019-2030)
9.4 Asia Drug Repositioning Market Size by Region
9.4.1 Asia Drug Repositioning Market Size by Region: 2019 VS 2023 VS 2030
9.4.2 Asia Drug Repositioning Market Size by Region (2019-2024)
9.4.3 Asia Drug Repositioning Market Size by Region (2025-2030)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Drug Repositioning Market Size (2019-2030)
10.2 Middle East, Africa, and Latin America Drug Repositioning Market Size by Type
10.2.1 Middle East, Africa, and Latin America Drug Repositioning Market Size by Type (2019-2024)
10.2.2 Middle East, Africa, and Latin America Drug Repositioning Market Size by Type (2025-2030)
10.2.3 Middle East, Africa, and Latin America Drug Repositioning Market Share by Type (2019-2030)
10.3 Middle East, Africa, and Latin America Drug Repositioning Market Size by Application
10.3.1 Middle East, Africa, and Latin America Drug Repositioning Market Size by Application (2019-2024)
10.3.2 Middle East, Africa, and Latin America Drug Repositioning Market Size by Application (2025-2030)
10.3.3 Middle East, Africa, and Latin America Drug Repositioning Market Share by Application (2019-2030)
10.4 Middle East, Africa, and Latin America Drug Repositioning Market Size by Country
10.4.1 Middle East, Africa, and Latin America Drug Repositioning Market Size by Country: 2019 VS 2023 VS 2030
10.4.2 Middle East, Africa, and Latin America Drug Repositioning Market Size by Country (2019-2024)
10.4.3 Middle East, Africa, and Latin America Drug Repositioning Market Size by Country (2025-2030)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Teva
11.1.1 Teva Company Details
11.1.2 Teva Business Overview
11.1.3 Teva Drug Repositioning Introduction
11.1.4 Teva Revenue in Drug Repositioning Business (2019-2024)
11.1.5 Teva Recent Developments
11.2 Novartis
11.2.1 Novartis Company Details
11.2.2 Novartis Business Overview
11.2.3 Novartis Drug Repositioning Introduction
11.2.4 Novartis Revenue in Drug Repositioning Business (2019-2024)
11.2.5 Novartis Recent Developments
11.3 Mylan
11.3.1 Mylan Company Details
11.3.2 Mylan Business Overview
11.3.3 Mylan Drug Repositioning Introduction
11.3.4 Mylan Revenue in Drug Repositioning Business (2019-2024)
11.3.5 Mylan Recent Developments
11.4 Johnson & Johnson
11.4.1 Johnson & Johnson Company Details
11.4.2 Johnson & Johnson Business Overview
11.4.3 Johnson & Johnson Drug Repositioning Introduction
11.4.4 Johnson & Johnson Revenue in Drug Repositioning Business (2019-2024)
11.4.5 Johnson & Johnson Recent Developments
11.5 Pfizer
11.5.1 Pfizer Company Details
11.5.2 Pfizer Business Overview
11.5.3 Pfizer Drug Repositioning Introduction
11.5.4 Pfizer Revenue in Drug Repositioning Business (2019-2024)
11.5.5 Pfizer Recent Developments
11.6 Bausch Health
11.6.1 Bausch Health Company Details
11.6.2 Bausch Health Business Overview
11.6.3 Bausch Health Drug Repositioning Introduction
11.6.4 Bausch Health Revenue in Drug Repositioning Business (2019-2024)
11.6.5 Bausch Health Recent Developments
11.7 GSK
11.7.1 GSK Company Details
11.7.2 GSK Business Overview
11.7.3 GSK Drug Repositioning Introduction
11.7.4 GSK Revenue in Drug Repositioning Business (2019-2024)
11.7.5 GSK Recent Developments
11.8 ChemRar Group
11.8.1 ChemRar Group Company Details
11.8.2 ChemRar Group Business Overview
11.8.3 ChemRar Group Drug Repositioning Introduction
11.8.4 ChemRar Group Revenue in Drug Repositioning Business (2019-2024)
11.8.5 ChemRar Group Recent Developments
11.9 Glenmark
11.9.1 Glenmark Company Details
11.9.2 Glenmark Business Overview
11.9.3 Glenmark Drug Repositioning Introduction
11.9.4 Glenmark Revenue in Drug Repositioning Business (2019-2024)
11.9.5 Glenmark Recent Developments
11.10 Fujifilm
11.10.1 Fujifilm Company Details
11.10.2 Fujifilm Business Overview
11.10.3 Fujifilm Drug Repositioning Introduction
11.10.4 Fujifilm Revenue in Drug Repositioning Business (2019-2024)
11.10.5 Fujifilm Recent Developments
11.11 Dr. Reddy
11.11.1 Dr. Reddy Company Details
11.11.2 Dr. Reddy Business Overview
11.11.3 Dr. Reddy Drug Repositioning Introduction
11.11.4 Dr. Reddy Revenue in Drug Repositioning Business (2019-2024)
11.11.5 Dr. Reddy Recent Developments
11.12 R-Pharma
11.12.1 R-Pharma Company Details
11.12.2 R-Pharma Business Overview
11.12.3 R-Pharma Drug Repositioning Introduction
11.12.4 R-Pharma Revenue in Drug Repositioning Business (2019-2024)
11.12.5 R-Pharma Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
FEATURED COMPANIES
Novartis
Johnson & Johnson
Bausch Health
GSK
ChemRar Group
Glenmark
Fujifilm
Dr. Reddy
R-Pharma
Pfizer Inc
TEVA
Mylan NV
List of Tables
    Table 1. Global Drug Repositioning Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030
    Table 2. Key Players of Generic Drugs
    Table 3. Key Players of Clinical Trial Failed Drugs
    Table 4. Global Drug Repositioning Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030
    Table 5. Global Drug Repositioning Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 6. Global Drug Repositioning Market Size by Region (2019-2024) & (US$ Million)
    Table 7. Global Drug Repositioning Market Share by Region (2019-2024)
    Table 8. Global Drug Repositioning Forecasted Market Size by Region (2025-2030) & (US$ Million)
    Table 9. Global Drug Repositioning Market Share by Region (2025-2030)
    Table 10. Drug Repositioning Market Trends
    Table 11. Drug Repositioning Market Drivers
    Table 12. Drug Repositioning Market Challenges
    Table 13. Drug Repositioning Market Restraints
    Table 14. Global Drug Repositioning Revenue by Players (2019-2024) & (US$ Million)
    Table 15. Global Drug Repositioning Revenue Share by Players (2019-2024)
    Table 16. Global Top Drug Repositioning by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Drug Repositioning as of 2023)
    Table 17. Global Drug Repositioning Industry Ranking 2022 VS 2023 VS 2024
    Table 18. Global 5 Largest Players Market Share by Drug Repositioning Revenue (CR5 and HHI) & (2019-2024)
    Table 19. Global Key Players of Drug Repositioning, Headquarters and Area Served
    Table 20. Global Key Players of Drug Repositioning, Product and Application
    Table 21. Global Key Players of Drug Repositioning, Product and Application
    Table 22. Mergers & Acquisitions, Expansion Plans
    Table 23. Global Drug Repositioning Market Size by Type (2019-2024) & (US$ Million)
    Table 24. Global Drug Repositioning Revenue Market Share by Type (2019-2024)
    Table 25. Global Drug Repositioning Forecasted Market Size by Type (2025-2030) & (US$ Million)
    Table 26. Global Drug Repositioning Revenue Market Share by Type (2025-2030)
    Table 27. Global Drug Repositioning Market Size by Application (2019-2024) & (US$ Million)
    Table 28. Global Drug Repositioning Revenue Share by Application (2019-2024)
    Table 29. Global Drug Repositioning Forecasted Market Size by Application (2025-2030) & (US$ Million)
    Table 30. Global Drug Repositioning Revenue Share by Application (2025-2030)
    Table 31. North America Drug Repositioning Market Size by Type (2019-2024) & (US$ Million)
    Table 32. North America Drug Repositioning Market Size by Type (2025-2030) & (US$ Million)
    Table 33. North America Drug Repositioning Market Size by Application (2019-2024) & (US$ Million)
    Table 34. North America Drug Repositioning Market Size by Application (2025-2030) & (US$ Million)
    Table 35. North America Drug Repositioning Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 36. North America Drug Repositioning Market Size by Country (2019-2024) & (US$ Million)
    Table 37. North America Drug Repositioning Market Size by Country (2025-2030) & (US$ Million)
    Table 38. Europe Drug Repositioning Market Size by Type (2019-2024) & (US$ Million)
    Table 39. Europe Drug Repositioning Market Size by Type (2025-2030) & (US$ Million)
    Table 40. Europe Drug Repositioning Market Size by Application (2019-2024) & (US$ Million)
    Table 41. Europe Drug Repositioning Market Size by Application (2025-2030) & (US$ Million)
    Table 42. Europe Drug Repositioning Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 43. Europe Drug Repositioning Market Size by Country (2019-2024) & (US$ Million)
    Table 44. Europe Drug Repositioning Market Size by Country (2025-2030) & (US$ Million)
    Table 45. China Drug Repositioning Market Size by Type (2019-2024) & (US$ Million)
    Table 46. China Drug Repositioning Market Size by Type (2025-2030) & (US$ Million)
    Table 47. China Drug Repositioning Market Size by Application (2019-2024) & (US$ Million)
    Table 48. China Drug Repositioning Market Size by Application (2025-2030) & (US$ Million)
    Table 49. Asia Drug Repositioning Market Size by Type (2019-2024) & (US$ Million)
    Table 50. Asia Drug Repositioning Market Size by Type (2025-2030) & (US$ Million)
    Table 51. Asia Drug Repositioning Market Size by Application (2019-2024) & (US$ Million)
    Table 52. Asia Drug Repositioning Market Size by Application (2025-2030) & (US$ Million)
    Table 53. Asia Drug Repositioning Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 54. Asia Drug Repositioning Market Size by Region (2019-2024) & (US$ Million)
    Table 55. Asia Drug Repositioning Market Size by Region (2025-2030) & (US$ Million)
    Table 56. Middle East, Africa, and Latin America Drug Repositioning Market Size by Type (2019-2024) & (US$ Million)
    Table 57. Middle East, Africa, and Latin America Drug Repositioning Market Size by Type (2025-2030) & (US$ Million)
    Table 58. Middle East, Africa, and Latin America Drug Repositioning Market Size by Application (2019-2024) & (US$ Million)
    Table 59. Middle East, Africa, and Latin America Drug Repositioning Market Size by Application (2025-2030) & (US$ Million)
    Table 60. Middle East, Africa, and Latin America Drug Repositioning Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 61. Middle East, Africa, and Latin America Drug Repositioning Market Size by Country (2019-2024) & (US$ Million)
    Table 62. Middle East, Africa, and Latin America Drug Repositioning Market Size by Country (2025-2030) & (US$ Million)
    Table 63. Teva Company Details
    Table 64. Teva Business Overview
    Table 65. Teva Drug Repositioning Product
    Table 66. Teva Revenue in Drug Repositioning Business (2019-2024) & (US$ Million)
    Table 67. Teva Recent Developments
    Table 68. Novartis Company Details
    Table 69. Novartis Business Overview
    Table 70. Novartis Drug Repositioning Product
    Table 71. Novartis Revenue in Drug Repositioning Business (2019-2024) & (US$ Million)
    Table 72. Novartis Recent Developments
    Table 73. Mylan Company Details
    Table 74. Mylan Business Overview
    Table 75. Mylan Drug Repositioning Product
    Table 76. Mylan Revenue in Drug Repositioning Business (2019-2024) & (US$ Million)
    Table 77. Mylan Recent Developments
    Table 78. Johnson & Johnson Company Details
    Table 79. Johnson & Johnson Business Overview
    Table 80. Johnson & Johnson Drug Repositioning Product
    Table 81. Johnson & Johnson Revenue in Drug Repositioning Business (2019-2024) & (US$ Million)
    Table 82. Johnson & Johnson Recent Developments
    Table 83. Pfizer Company Details
    Table 84. Pfizer Business Overview
    Table 85. Pfizer Drug Repositioning Product
    Table 86. Pfizer Revenue in Drug Repositioning Business (2019-2024) & (US$ Million)
    Table 87. Pfizer Recent Developments
    Table 88. Bausch Health Company Details
    Table 89. Bausch Health Business Overview
    Table 90. Bausch Health Drug Repositioning Product
    Table 91. Bausch Health Revenue in Drug Repositioning Business (2019-2024) & (US$ Million)
    Table 92. Bausch Health Recent Developments
    Table 93. GSK Company Details
    Table 94. GSK Business Overview
    Table 95. GSK Drug Repositioning Product
    Table 96. GSK Revenue in Drug Repositioning Business (2019-2024) & (US$ Million)
    Table 97. GSK Recent Developments
    Table 98. ChemRar Group Company Details
    Table 99. ChemRar Group Business Overview
    Table 100. ChemRar Group Drug Repositioning Product
    Table 101. ChemRar Group Revenue in Drug Repositioning Business (2019-2024) & (US$ Million)
    Table 102. ChemRar Group Recent Developments
    Table 103. Glenmark Company Details
    Table 104. Glenmark Business Overview
    Table 105. Glenmark Drug Repositioning Product
    Table 106. Glenmark Revenue in Drug Repositioning Business (2019-2024) & (US$ Million)
    Table 107. Glenmark Recent Developments
    Table 108. Fujifilm Company Details
    Table 109. Fujifilm Business Overview
    Table 110. Fujifilm Drug Repositioning Product
    Table 111. Fujifilm Revenue in Drug Repositioning Business (2019-2024) & (US$ Million)
    Table 112. Fujifilm Recent Developments
    Table 113. Dr. Reddy Company Details
    Table 114. Dr. Reddy Business Overview
    Table 115. Dr. Reddy Drug Repositioning Product
    Table 116. Dr. Reddy Revenue in Drug Repositioning Business (2019-2024) & (US$ Million)
    Table 117. Dr. Reddy Recent Developments
    Table 118. R-Pharma Company Details
    Table 119. R-Pharma Business Overview
    Table 120. R-Pharma Drug Repositioning Product
    Table 121. R-Pharma Revenue in Drug Repositioning Business (2019-2024) & (US$ Million)
    Table 122. R-Pharma Recent Developments
    Table 123. Research Programs/Design for This Report
    Table 124. Key Data Information from Secondary Sources
    Table 125. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Drug Repositioning Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 2. Global Drug Repositioning Market Share by Type: 2023 VS 2030
    Figure 3. Generic Drugs Features
    Figure 4. Clinical Trial Failed Drugs Features
    Figure 5. Global Drug Repositioning Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 6. Global Drug Repositioning Market Share by Application: 2023 VS 2030
    Figure 7. Cardiovascular Diseases Case Studies
    Figure 8. Mental Illness Case Studies
    Figure 9. Cancer Case Studies
    Figure 10. Others Case Studies
    Figure 11. Drug Repositioning Report Years Considered
    Figure 12. Global Drug Repositioning Market Size (US$ Million), Year-over-Year: 2019-2030
    Figure 13. Global Drug Repositioning Market Size, (US$ Million), 2019 VS 2023 VS 2030
    Figure 14. Global Drug Repositioning Market Share by Region: 2023 VS 2030
    Figure 15. Global Drug Repositioning Market Share by Players in 2023
    Figure 16. Global Top Drug Repositioning Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Drug Repositioning as of 2023)
    Figure 17. The Top 10 and 5 Players Market Share by Drug Repositioning Revenue in 2023
    Figure 18. North America Drug Repositioning Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 19. North America Drug Repositioning Market Share by Type (2019-2030)
    Figure 20. North America Drug Repositioning Market Share by Application (2019-2030)
    Figure 21. North America Drug Repositioning Market Share by Country (2019-2030)
    Figure 22. United States Drug Repositioning Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 23. Canada Drug Repositioning Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 24. Europe Drug Repositioning Market Size YoY (2019-2030) & (US$ Million)
    Figure 25. Europe Drug Repositioning Market Share by Type (2019-2030)
    Figure 26. Europe Drug Repositioning Market Share by Application (2019-2030)
    Figure 27. Europe Drug Repositioning Market Share by Country (2019-2030)
    Figure 28. Germany Drug Repositioning Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 29. France Drug Repositioning Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 30. U.K. Drug Repositioning Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 31. Italy Drug Repositioning Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 32. Russia Drug Repositioning Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 33. Nordic Countries Drug Repositioning Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 34. China Drug Repositioning Market Size YoY (2019-2030) & (US$ Million)
    Figure 35. China Drug Repositioning Market Share by Type (2019-2030)
    Figure 36. China Drug Repositioning Market Share by Application (2019-2030)
    Figure 37. Asia Drug Repositioning Market Size YoY (2019-2030) & (US$ Million)
    Figure 38. Asia Drug Repositioning Market Share by Type (2019-2030)
    Figure 39. Asia Drug Repositioning Market Share by Application (2019-2030)
    Figure 40. Asia Drug Repositioning Market Share by Region (2019-2030)
    Figure 41. Japan Drug Repositioning Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 42. South Korea Drug Repositioning Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 43. China Taiwan Drug Repositioning Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 44. Southeast Asia Drug Repositioning Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 45. India Drug Repositioning Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 46. Australia Drug Repositioning Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 47. Middle East, Africa, and Latin America Drug Repositioning Market Size YoY (2019-2030) & (US$ Million)
    Figure 48. Middle East, Africa, and Latin America Drug Repositioning Market Share by Type (2019-2030)
    Figure 49. Middle East, Africa, and Latin America Drug Repositioning Market Share by Application (2019-2030)
    Figure 50. Middle East, Africa, and Latin America Drug Repositioning Market Share by Country (2019-2030)
    Figure 51. Brazil Drug Repositioning Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 52. Mexico Drug Repositioning Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 53. Turkey Drug Repositioning Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 54. Saudi Arabia Drug Repositioning Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 55. Israel Drug Repositioning Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 56. GCC Countries Drug Repositioning Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 57. Teva Revenue Growth Rate in Drug Repositioning Business (2019-2024)
    Figure 58. Novartis Revenue Growth Rate in Drug Repositioning Business (2019-2024)
    Figure 59. Mylan Revenue Growth Rate in Drug Repositioning Business (2019-2024)
    Figure 60. Johnson & Johnson Revenue Growth Rate in Drug Repositioning Business (2019-2024)
    Figure 61. Pfizer Revenue Growth Rate in Drug Repositioning Business (2019-2024)
    Figure 62. Bausch Health Revenue Growth Rate in Drug Repositioning Business (2019-2024)
    Figure 63. GSK Revenue Growth Rate in Drug Repositioning Business (2019-2024)
    Figure 64. ChemRar Group Revenue Growth Rate in Drug Repositioning Business (2019-2024)
    Figure 65. Glenmark Revenue Growth Rate in Drug Repositioning Business (2019-2024)
    Figure 66. Fujifilm Revenue Growth Rate in Drug Repositioning Business (2019-2024)
    Figure 67. Dr. Reddy Revenue Growth Rate in Drug Repositioning Business (2019-2024)
    Figure 68. R-Pharma Revenue Growth Rate in Drug Repositioning Business (2019-2024)
    Figure 69. Bottom-up and Top-down Approaches for This Report
    Figure 70. Data Triangulation
    Figure 71. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$4900

This license allows only one user to access the PDF.
Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Lukasiewicz Research Network

SIMILAR REPORTS

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions